Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Role for WDR5 in Integrating Threonine 11 Phosphorylation to Lysine 4 Methylation on Histone H3 during Androgen Signaling and in Prostate Cancer
Ji-Young Kim, Taraswi Banerjee, Aurimas Vinckevicius, et al.
Molecular Cell (2014) Vol. 54, Iss. 4, pp. 613-625
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5
Peng Gu, Xu Chen, Ruihui Xie, et al.
Molecular Therapy (2017) Vol. 25, Iss. 8, pp. 1959-1973
Open Access | Times Cited: 178
Mechanisms of Taxane Resistance
Sara Maloney, Camden A. Hoover, Lorena V. Morejon-Lasso, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3323-3323
Open Access | Times Cited: 145
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer
Alessandro Carugo, Giannicola Genovese, Sahil Seth, et al.
Cell Reports (2016) Vol. 16, Iss. 1, pp. 133-147
Open Access | Times Cited: 125
Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation
Xu Chen, Weibin Xie, Peng Gu, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 118
GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
Bin He, Rainer B. Lanz, Warren Fiskus, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 51, pp. 18261-18266
Open Access | Times Cited: 113
TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression
Ken‐ichi Takayama, Aya Misawa, Takashi Suzuki, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 104
WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
Yuting Sun, Jessica L. Bell, Daniel R. Carter, et al.
Cancer Research (2015) Vol. 75, Iss. 23, pp. 5143-5154
Open Access | Times Cited: 94
Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin
Agnieszka Bochyńska, Juliane Lüscher‐Firzlaff, Bernhard Lüscher
Cells (2018) Vol. 7, Iss. 3, pp. 17-17
Open Access | Times Cited: 88
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review
Hope S. Rugo, Ira Jacobs, Shikhar Sharma, et al.
Advances in Therapy (2020) Vol. 37, Iss. 7, pp. 3059-3082
Open Access | Times Cited: 87
Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer
Rajita Vatapalli, Vinay Sagar, Yara Rodríguez, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 86
Phosphorylation of endothelial histone H3.3 serine 31 by PKN1 links flow-induced signaling to proatherogenic gene expression
Young‐June Jin, Guozheng Liang, Rui Li, et al.
Nature Cardiovascular Research (2025)
Open Access | Times Cited: 1
PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407
Xin Tan, Shuai Chen, Jiangxue Wu, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 3, pp. e2686-e2686
Open Access | Times Cited: 81
The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer
Kebin Lu, Tao He, Xiaomin Si, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 73
WDR5 Expression Is Prognostic of Breast Cancer Outcome
Xiaofeng Dai, Wenwen Guo, Chunjun Zhan, et al.
PLoS ONE (2015) Vol. 10, Iss. 9, pp. e0124964-e0124964
Open Access | Times Cited: 68
WDR5 high expression and its effect on tumorigenesis in leukemia
Zheng Ge, E Song, Yuka Imamura Kawasawa, et al.
Oncotarget (2016) Vol. 7, Iss. 25, pp. 37740-37754
Open Access | Times Cited: 65
WDR5 is a conserved regulator of protein synthesis gene expression
Audra F. Bryan, Jing Wang, Gregory C. Howard, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 6, pp. 2924-2941
Open Access | Times Cited: 57
The MYC–WDR5 Nexus and Cancer
Lance R. Thomas, Audra F. Bryan, April M. Weissmiller, et al.
Cancer Research (2015) Vol. 75, Iss. 19, pp. 4012-4015
Open Access | Times Cited: 60
Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells
Zhenhua Yang, Kushani Shah, Alireza Khodadadi‐Jamayran, et al.
The Journal of Experimental Medicine (2016) Vol. 213, Iss. 11, pp. 2349-2364
Open Access | Times Cited: 58
The complex activities of the SET1/MLL complex core subunits in development and disease
Hao Jiang
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2020) Vol. 1863, Iss. 7, pp. 194560-194560
Open Access | Times Cited: 43
Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective
Xin Chen, Junjie Xu, Xianghan Wang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 10537-10556
Closed Access | Times Cited: 38
PRMT5: a putative oncogene and therapeutic target in prostate cancer
Elena Beketova, Jake L. Owens, Andrew M. Asberry, et al.
Cancer Gene Therapy (2021) Vol. 29, Iss. 3-4, pp. 264-276
Open Access | Times Cited: 33
Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth
Daisuke Obinata, Ken‐ichi Takayama, Kyoko Fujiwara, et al.
Oncogene (2016) Vol. 35, Iss. 49, pp. 6350-6358
Open Access | Times Cited: 44
lncRNA GCAWKR Promotes Gastric Cancer Development by Scaffolding the Chromatin Modification Factors WDR5 and KAT2A
Mingzhe Ma, Yan Zhang, Mingzhe Weng, et al.
Molecular Therapy (2018) Vol. 26, Iss. 11, pp. 2658-2668
Open Access | Times Cited: 44
WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage
Beth K. Neilsen, Binita Chakraborty, Jamie L. McCall, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 39
lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System
Dominik A. Barth, Jaroslav Juráček, Ondřej Slabý, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2148-2148
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top